IL137557A0 - A composition containing a tnf-2-converting enzyme polypeptide in crystalline form and methods for the preparation thereof and for using the same - Google Patents

A composition containing a tnf-2-converting enzyme polypeptide in crystalline form and methods for the preparation thereof and for using the same

Info

Publication number
IL137557A0
IL137557A0 IL13755799A IL13755799A IL137557A0 IL 137557 A0 IL137557 A0 IL 137557A0 IL 13755799 A IL13755799 A IL 13755799A IL 13755799 A IL13755799 A IL 13755799A IL 137557 A0 IL137557 A0 IL 137557A0
Authority
IL
Israel
Prior art keywords
tnf
preparation
methods
composition containing
same
Prior art date
Application number
IL13755799A
Other languages
English (en)
Original Assignee
Immunex Corp
American Home Prod
Max Planck Inst For Biochemist
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp, American Home Prod, Max Planck Inst For Biochemist filed Critical Immunex Corp
Publication of IL137557A0 publication Critical patent/IL137557A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
IL13755799A 1998-02-04 1999-02-03 A composition containing a tnf-2-converting enzyme polypeptide in crystalline form and methods for the preparation thereof and for using the same IL137557A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7370998P 1998-02-04 1998-02-04
US5008398A 1998-03-30 1998-03-30
US11747699P 1999-01-27 1999-01-27
PCT/US1999/002185 WO1999040182A2 (fr) 1998-02-04 1999-02-03 Enzyme de conversion cristalline du facteur tnf alpha et ses utilisations

Publications (1)

Publication Number Publication Date
IL137557A0 true IL137557A0 (en) 2001-07-24

Family

ID=27367666

Family Applications (3)

Application Number Title Priority Date Filing Date
IL16351399A IL163513A0 (en) 1998-02-04 1999-02-03 A composition containing a tnf-2-converting enzymepolypeptidein crystalline form and methods for thepreparation thereof
IL13755799A IL137557A0 (en) 1998-02-04 1999-02-03 A composition containing a tnf-2-converting enzyme polypeptide in crystalline form and methods for the preparation thereof and for using the same
IL163513A IL163513A (en) 1998-02-04 2004-08-12 Composition containing a tnf- 2 - converting enzyme polypeptide in crystalline form and methods for the preparation thereof and for using the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL16351399A IL163513A0 (en) 1998-02-04 1999-02-03 A composition containing a tnf-2-converting enzymepolypeptidein crystalline form and methods for thepreparation thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL163513A IL163513A (en) 1998-02-04 2004-08-12 Composition containing a tnf- 2 - converting enzyme polypeptide in crystalline form and methods for the preparation thereof and for using the same

Country Status (15)

Country Link
EP (1) EP1053304B1 (fr)
JP (1) JP2004503202A (fr)
CN (1) CN1342200A (fr)
AR (2) AR015513A1 (fr)
AT (1) ATE366303T1 (fr)
AU (1) AU2574099A (fr)
CA (1) CA2319040A1 (fr)
DE (1) DE69936445T2 (fr)
DK (1) DK1053304T3 (fr)
ES (1) ES2293718T3 (fr)
HU (1) HUP0101596A1 (fr)
IL (3) IL163513A0 (fr)
NO (1) NO20003687L (fr)
NZ (1) NZ505959A (fr)
WO (1) WO1999040182A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406901B1 (en) 1995-06-08 2002-06-18 Immunex Corporation TNF-a converting enzyme
AU2002233916A1 (en) * 2000-08-03 2002-04-29 Albert Einstein College Of Medicine Isocitrate lyase enzyme from mycobacterium tuberculosis and inhibitory agents to combat persistent infection
US7138264B1 (en) 2002-05-24 2006-11-21 Schering Corporation Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof
WO2005073400A2 (fr) * 2004-01-26 2005-08-11 University Of Massachusetts Procede d'identification de modulateurs de proteine kinase et leurs utilisations
TWI516274B (zh) * 2013-11-27 2016-01-11 財團法人工業技術研究院 應用於生髮之方法及醫藥組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594106A (en) * 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
US5702935A (en) * 1994-04-28 1997-12-30 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method and compounds for inhibiting lipid biosynthesis of bacteria and plants
PT830130E (pt) * 1995-06-08 2004-11-30 Immunex Corp Enzima de conversao de tnf-alfa
AU6960696A (en) * 1995-08-30 1997-03-19 Ariad Pharmaceuticals, Inc. Crystalline zap family proteins
AU1115797A (en) * 1995-10-26 1997-05-15 Alessandra D'azzo Protective protein/cathepsin a and precursor: crystallization, x-ray diffraction, three-dimensional structure determination and rational drug design
JP2000507943A (ja) * 1996-03-26 2000-06-27 グラクソ、グループ、リミテッド 腫瘍壊死因子αコンバーターゼ

Also Published As

Publication number Publication date
CN1342200A (zh) 2002-03-27
AR015513A1 (es) 2001-05-02
NO20003687L (no) 2000-09-19
WO1999040182A2 (fr) 1999-08-12
AU2574099A (en) 1999-08-23
EP1053304B1 (fr) 2007-07-04
AR024804A1 (es) 2002-10-23
DK1053304T3 (da) 2007-11-05
IL163513A0 (en) 2005-12-18
DE69936445T2 (de) 2008-04-10
HUP0101596A1 (hu) 2001-08-28
CA2319040A1 (fr) 1999-08-12
WO1999040182A3 (fr) 1999-10-07
ATE366303T1 (de) 2007-07-15
IL163513A (en) 2007-03-08
NZ505959A (en) 2003-05-30
JP2004503202A (ja) 2004-02-05
EP1053304A2 (fr) 2000-11-22
ES2293718T3 (es) 2008-03-16
NO20003687D0 (no) 2000-07-18
DE69936445D1 (de) 2007-08-16

Similar Documents

Publication Publication Date Title
EP0937684A4 (fr) Hydrogenotitanates de lithium et leur procede de fabrication
HUP0000302A3 (en) Ob fusion protein compositions and methods
AU3362599A (en) Modified textile and other materials and methods for their preparation
AU2091499A (en) Permeable compositions and methods for their preparation
AU3116800A (en) Compositions and methods for altering cell migration
IL127032A0 (en) A solid clear composition and a method for preparing the same
HU9701090D0 (en) Microporous crystalline material, process for its preparation and its use in detergent compositions
AU3661199A (en) Novel polypeptide growth factors and materials and methods for making them
HUP0102109A3 (en) Sweetener composition and uses thereof
AU749278C (en) Composition for use in dementia
GB9412629D0 (en) Improvements in crystal growth
GB9803506D0 (en) Composition and method
IL137557A0 (en) A composition containing a tnf-2-converting enzyme polypeptide in crystalline form and methods for the preparation thereof and for using the same
AU2346800A (en) Compositions and methods using cell fusion
IL109717A0 (en) Cell surface proteins and methods for the preparation and use thereof
GB9814869D0 (en) Process and composition
EP0871644A4 (fr) Compositions de molecule-1 d'adherence entre les plaquettes et les cellules endotheliales et procedes d'utilisation
HUP0102002A3 (en) Biologically active composition and process for its preparation
GB9805630D0 (en) Improvements in creamic materials
AU8048598A (en) Powder composition and process for the preparation thereof
AU5306999A (en) Gel-type pocket fuel composition and process for preparing the same
HK1025951A1 (en) Cephalonsporin crystals and process for their preparation
AU4628897A (en) Improvements in fastenings
AU9758498A (en) Novel aspartame crystals and process for the preparation thereof
AU1481197A (en) A composition and a method for preparing the composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees